Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 201525
Company: SANDOZ
Company: SANDOZ
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DOCETAXEL | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | AP | No | No |
DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | AP | No | No |
DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
06/29/2011 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201525s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/201525s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/201525_docetaxel_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/201525Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
09/21/2023 | SUPPL-24 | Labeling-Package Insert, Labeling-Patient Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201525s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/201525Orig1s024ltr.pdf | |
01/13/2021 | SUPPL-22 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201525s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/201525Orig1s022ltr.pdf | |
08/11/2020 | SUPPL-20 | Labeling-Package Insert, Labeling-Patient Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201525s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/201525Orig1s020ltr.pdf | |
01/06/2020 | SUPPL-19 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201525s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/201525Orig1s019ltr.pdf | |
03/27/2019 | SUPPL-17 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201525s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/201525Orig1s016, 201525Orig1s017ltr.pdf | |
03/27/2019 | SUPPL-16 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201525s016s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/201525Orig1s016, 201525Orig1s017ltr.pdf | |
10/21/2016 | SUPPL-12 | Labeling-Package Insert |
Letter (PDF)
Review (PDF) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/201525Orig1s012ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/201525Orig1s012.pdf |
07/25/2016 | SUPPL-11 | Manufacturing (CMC) |
Label is not available on this site. |
||
11/04/2014 | SUPPL-9 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201525s008s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/201525Orig1s008,s009ltr.pdf | |
11/04/2014 | SUPPL-8 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201525s008s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/201525Orig1s008,s009ltr.pdf | |
08/18/2014 | SUPPL-7 | Manufacturing (CMC) |
Label is not available on this site. |
||
04/23/2014 | SUPPL-3 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201525s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/201525Orig1s003ltr.pdf | |
03/15/2012 | SUPPL-2 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201525s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/201525s002ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
09/21/2023 | SUPPL-24 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201525s024lbl.pdf | |
09/21/2023 | SUPPL-24 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201525s024lbl.pdf | |
01/13/2021 | SUPPL-22 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201525s022lbl.pdf | |
08/11/2020 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201525s020lbl.pdf | |
08/11/2020 | SUPPL-20 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201525s020lbl.pdf | |
01/06/2020 | SUPPL-19 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201525s019lbl.pdf | |
03/27/2019 | SUPPL-17 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201525s016s017lbl.pdf | |
03/27/2019 | SUPPL-16 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201525s016s017lbl.pdf | |
11/04/2014 | SUPPL-9 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201525s008s009lbl.pdf | |
11/04/2014 | SUPPL-8 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201525s008s009lbl.pdf | |
04/23/2014 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201525s003lbl.pdf | |
03/15/2012 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/201525s002lbl.pdf | |
06/29/2011 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201525s000lbl.pdf |
DOCETAXEL
INJECTABLE;INJECTION; 20MG/2ML (10MG/ML)
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
DOCETAXEL | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 215744 | ALEMBIC |
DOCETAXEL | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 214575 | EUGIA PHARMA |
DOCETAXEL | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 213510 | GLAND PHARMA LTD |
DOCETAXEL | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | Yes | AP | 022234 | HOSPIRA INC |
DOCETAXEL | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 209634 | MEITHEAL |
DOCETAXEL | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 210072 | MYLAN LABS LTD |
DOCETAXEL | DOCETAXEL | 20MG/2ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 201525 | SANDOZ |
INJECTABLE;INJECTION; 80MG/8ML (10MG/ML)
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 215744 | ALEMBIC |
DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 214575 | EUGIA PHARMA |
DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 213510 | GLAND PHARMA LTD |
DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | Yes | AP | 022234 | HOSPIRA INC |
DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 209634 | MEITHEAL |
DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 210848 | MYLAN LABS LTD |
DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 207563 | NOVAST LABS |
DOCETAXEL | DOCETAXEL | 80MG/8ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 201525 | SANDOZ |
INJECTABLE;INJECTION; 160MG/16ML (10MG/ML)
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 215744 | ALEMBIC |
DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 214575 | EUGIA PHARMA |
DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 213510 | GLAND PHARMA LTD |
DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | Yes | AP | 022234 | HOSPIRA INC |
DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 209634 | MEITHEAL |
DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 208859 | MYLAN LABS LTD |
DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 207563 | NOVAST LABS |
DOCETAXEL | DOCETAXEL | 160MG/16ML (10MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 201525 | SANDOZ |